Comparative Pharmacokinetics and Food-Effect Bioavailability of a Sprinkle Formulation of Lubiprostone After Oral Administration in Healthy Volunteers
Phase of Trial: Phase III
Latest Information Update: 10 May 2017
At a glance
- Drugs Lubiprostone (Primary)
- Indications Constipation; Irritable bowel syndrome
- Focus Pharmacokinetics
- Sponsors Sucampo AG
- 08 Mar 2017 Top line results from this trial will be available in Q1 2017, according to a Sucampo Pharmaceuticals media release.
- 08 Mar 2017 Status changed from active, no longer recruiting to completed, according to a Sucampo Pharmaceuticals media release.
- 09 Jan 2017 New trial record